ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Human Influenza
Communicable Diseases
Post-Acute COVID-19 Syndrome
Syndrome
Pneumonia

COVID-19 trials near Baltimore, MD, USA:

Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics (COV19-APTP-B)

that suggests the potential for clinical benefit of COVID-19 patients.1. Treat Infection of Multiple Gene Mutation COVID-19...

Active, not recruiting
Covid19
Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection

Early Phase 1

Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair

North Bethesda, Maryland, United States

Comprehensive Imaging Exam of Convalesced COVID-19 Patients

COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocardium that le-...

Invitation-only
COVID-19
COVID Long-Haul
Other: Magnetic Resonance Imaging
Other: Ultra-High Resolution Computed Tomography (CT) Scan
Johns Hopkins University
Johns Hopkins University

Baltimore, Maryland, United States

A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2

A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...

Active, not recruiting
COVID-19
SARS-CoV-2
Drug: VYD222 (pemivibart)
Drug: Normal saline

Phase 3

Invivyd

Silver Spring, Maryland, United States and 17 other locations

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test (ASPIRE)

Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.

Active, not recruiting
Covid19
Diagnostic Test: Fingerstick
Diagnostic Test: Saliva specimen
LumiraDx

Millersville, Maryland, United States and 6 other locations

COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study

a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =\<2500 U/mL SARS-CoV-2 S antibody concentr...

Active, not recruiting
COVID-19
Kidney Transplant
Biological: Sanofi-GSK monovalent (B.1.351) CoV2 preS dTM-AS03 COVID-19 vaccine

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Baltimore, Maryland, United States and 5 other locations

Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)

mild to severe acute respiratory distress syndrome (ARDS) due to COVID-19 resultant from 2019-nCoV coronavirus infection, or result...

Active, not recruiting
Covid19
ARDS, Human
Biological: Longeveron Mesenchymal Stem Cells (LMSCs)
Other: Placebo

Phase 1

Longeveron

Baltimore, Maryland, United States and 2 other locations

PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19

This study is an adaptive, randomized, double blind, platform trial evaluating promising investigational products (IP) for safety and efficacy as ear...

Enrolling
SARS-CoV-2
Drug: Upamostat
Drug: Placebo (PO)

Phase 2

Henry M. Jackson Foundation for the Advancement of Military Medicine

Baltimore, Maryland, United States and 5 other locations

A Study to Evaluate VXA-CoV2-3.1 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

(SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID...

Enrolling
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: COMIRNATY®

Phase 2

Vaxart

Baltimore, Maryland, United States and 144 other locations

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Baltimore, Maryland, United States and 214 other locations

Locations recently updated

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Baltimore, Maryland, United States and 66 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2024 Veeva Systems